Article
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.
Blood - 3 Aug 2017
Hu Zhilian, Liu Yang, Huarng Michael C, Menegatti Marzia, Reyon Deepak, Rost Megan S, Norris Zachary G, Richter Catherine E, Stapleton Alexandra N, Chi Neil C, Peyvandi Flora, Joung J Keith, Shavit Jordan A
Abstract excerpt
Deficiency of factor X (F10) in humans is a rare bleeding disorder with a heterogeneous phenotype and limited therapeutic options. Targeted disruption of F10 and other common pathway factors in mice results in embryonic/neonatal lethality with rapid resorption of homozygous mutants, hampering additional studies. Several of these mutants also display yolk sac vascular defects, suggesting a role for thrombin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
